Jane Street’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Buy
70,900
+15,200
+27% +$330K ﹤0.01% 5833
2025
Q4
$1.22M Buy
55,700
+11,000
+25% +$199K ﹤0.01% 5738
2025
Q3
$543K Hold
44,700
﹤0.01% 7677
2025
Q2
$833K Sell
44,700
-1,800
-4% -$35.6K ﹤0.01% 5966
2025
Q1
$891K Buy
+46,500
New +$1.36M ﹤0.01% 5789
2024
Q4
Sell
-52,500
Closed -$2.23M 10592
2024
Q3
$2.23M Buy
52,500
+47,200
+891% +$2M ﹤0.01% 4249
2024
Q2
$214K Buy
+5,300
New +$221K ﹤0.01% 8288
2024
Q1
Sell
-10,200
Closed -$302K 10082
2023
Q4
$302K Buy
+10,200
New +$212K ﹤0.01% 7591
2023
Q2
Sell
-5,700
Closed -$231K 9566
2023
Q1
$231K Sell
5,700
-24,200
-81% -$1M ﹤0.01% 7611
2022
Q4
$1.34M Buy
29,900
+7,900
+36% +$358K ﹤0.01% 4499
2022
Q3
$1.05M Sell
22,000
-6,000
-21% -$329K ﹤0.01% 5327
2022
Q2
$1.66M Buy
28,000
+3,300
+13% +$271K ﹤0.01% 4513
2022
Q1
$2.87M Buy
24,700
+18,600
+305% +$2.17M ﹤0.01% 4043
2021
Q4
$918K Sell
6,100
-17,500
-74% -$2.36M ﹤0.01% 6068
2021
Q3
$2.82M Buy
23,600
+9,100
+63% +$1M ﹤0.01% 3779
2021
Q2
$1.41M Sell
14,500
-10,000
-41% -$892K ﹤0.01% 5059
2021
Q1
$2.16M Sell
24,500
-38,800
-61% -$3.61M ﹤0.01% 3865
2020
Q4
$6.06M Buy
63,300
+16,100
+34% +$1.66M ﹤0.01% 1906
2020
Q3
$5.36M Sell
47,200
-10,400
-18% -$1.09M ﹤0.01% 1779
2020
Q2
$5.7M Buy
+57,600
New +$4.6M ﹤0.01% 1706
2020
Q1
Sell
-35,100
Closed -$2.09M 5973
2019
Q4
$2.09M Buy
35,100
+15,300
+77% +$944K ﹤0.01% 1889
2019
Q3
$1.17M Buy
19,800
+5,400
+38% +$345K ﹤0.01% 2420
2019
Q2
$929K Sell
14,400
-13,900
-49% -$897K ﹤0.01% 2797
2019
Q1
$1.8M Buy
+28,300
New +$1.49M ﹤0.01% 2148

Other funds holding TNDM

Jane Street's TNDM Position: Q1 2026 in Review

Jane Street sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 209,975 shares — an estimated $4.56M sold.

Jane Street first reported a position in TNDM in Q1 2014 and held it in 28 quarters. The position peaked at $16.7M in Q2 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Jane Street reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 209,975 Tandem Diabetes Care shares in Q1 2026, an estimated $4.56M.
  • Jane Street first reported a position in Tandem Diabetes Care in Q1 2014 and held it in 28 quarters.
  • Jane Street's Tandem Diabetes Care position peaked at $16.7M in Q2 2020.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.